Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Share Buyback

I don't think many have agreed with me when I have floated those same sentiments. As opposed to an acquisition that could possibly drain us of capital as they develop their product, a share buy back is a one time cost and has a direct correlation towards shareholder value. Imagine, imagine, oh imagine if all the monies spent on dividends were spent on share buyback. We have suffered long enough that many are ready to dump their shares. Should not be a problem finding sufficient sellers to reduce outstanding shares by 100 million. or more. Then continue acquisitions with subsequent MMP revenue.

Share
New Message
Please login to post a reply